Femasys (FEMY) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

FEMY Femasys

Watchlist

1.2600
-0.0700-5.26%

Close Nov 1 16:00 ET

1.2600
0.00000.00%

Post 19:33 ET

28.01MMarket Cap-1500P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Femasys Shares Are Trading Higher After the Company Announced It Received a U.S Patent for Its Permanent Birth Control Product FemBloc.
BenzingaNov 1 08:39 ET
Express News | Femasys Announces Issued U.S. Patent Covering Fembloc® Device for Female Permanent Birth Control
ReutersNov 1 08:31 ET
H.C. Wainwright Maintains Femasys(FEMY.US) With Buy Rating, Cuts Target Price to $12
Moomoo NewsOct 30 13:31 ET · Ratings
Express News | Femasys Announces Partnership With Boston IVF, Prominent Network of Fertility Centers, to Offer Femaseed
ReutersOct 30 09:00 ET
Femasys to Exhibit at ASRM 2024, Participate in KEEPR Education Program
TipRanksOct 10 08:36 ET
Femasys Announces Second Order From Strategic Distribution Partners
TipRanksOct 2 08:35 ET

Comments

Trytosaveabit

Yesterday 20:33

News

$Femasys (FEMY.US)$ Reuters
1 min ago
Femasys Announces Issued U.S. Patent Covering Fembloc® Device for Female Permanent Birth Control

Jaguar8

Yesterday 20:31

NEWS

$Femasys (FEMY.US)$
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
Femasys Inc. (NASDAQ: FEMY) announces the issuance of U.S. Patent No. 12,12796 by the USPTO for its FemBloc® permanent birth control device. The patent, expiring no earlier than 2039, strengthens the company's intellectual property position for its leading therapeutic product candidate. This adds to Femasys' portfolio of over 180 patents globally, protecting their suite of prod...

Trytosaveabit

Oct 30 08:02

News

$Femasys (FEMY.US)$ Reuters· 1 min ago
Femasys Announces Partnership With Boston IVF, Prominent Network of Fertility Centers, to Offer Femaseed

Jaguar8

Oct 2 07:40

NEWS

$Femasys (FEMY.US)$
Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments
ATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (NASDAQ:FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces that the Company has received its second order from its strategic distribut...

Trytosaveabit

Sep 11 07:36

Update

$Femasys (FEMY.US)$ Reuters
·3 mins ago
Femasys Secures Strategic Distribution Partnerships for Commercialization of Femaseed® for Over $1.3M in Spanish Market

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

FEMY Femasys

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target